One study found that ARRB2 is a potential prognostic indicator for progression and the chemotherapy response in bladder cancer, and overexpression of ARRB2 leads to reduced tumor growth and an enhanced response to chemotherapy [30]. Here, ARRB2 is linked to urinary bladder cancer.